Optiscan Imaging Limited (ASX:OIL)

Market Cap	91.89M
Revenue (ttm)	4.96M
Net Income (ttm)	-4.98M
Shares Out	835.34M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190,142
Average Volume	128,783
Open	0.1150
Previous Close	0.1200
Day's Range	0.1100 - 0.1200
52-Week Range	0.1000 - 0.2600
Beta	0.71
RSI	44.63
Earnings Date	May 28, 2025

About Optiscan Imaging

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States. It offers InVivage, an intra-oral endomicroscope for oral cancer imaging; InVue, a microscopic medical imaging device for precision surgery; and ViewnVivo, an endomicroscope for life sciences, pre-clinical and translational research. The company has a collaboration agreement with Mayo Clinic to...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1994
• Employees: 9
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OIL

Financial Performance

In 2024, Optiscan Imaging's revenue was 2.99 million, an increase of 14.06% compared to the previous year's 2.62 million. Losses were -6.06 million, 39.3% more than in 2023.